# Alcohol Consumption and DNA Methylation in a Mediterranean Cohort: A Focus on Oxidative Stress and Aging Biomarkers

**Authors:** Oscar Coltell, Eva M. Asensio, José V. Sorlí, Rebeca Fernández-Carrión, Carolina Ortega-Azorín, Rocío Barragán, Alejandro Perez-Fidalgo, Olga Portolés, Jose M. Ordovas, Dolores Corella

PMC · DOI: 10.3390/antiox15020197 · Antioxidants · 2026-02-02

## TL;DR

This study explores how alcohol affects DNA methylation and aging in a Mediterranean population, using both self-reported data and a DNA-based biomarker.

## Contribution

The study validates an epigenomic biomarker for alcohol consumption and identifies its associations with aging biomarkers in a Mediterranean cohort.

## Key findings

- The epigenomic biomarker showed significant but modest correlation with self-reported alcohol consumption.
- Alcohol intake was linked to hypomethylation at the SLC7A11 gene, involved in antioxidant defense.
- High alcohol intake was associated with shorter telomere length and increased biological age acceleration.

## Abstract

There is considerable interest in the connection between alcohol-induced oxidative stress, DNA methylation, antioxidants, and accelerated aging across diverse populations. Nevertheless, self-reported alcohol consumption is prone to bias, and objective biomarkers of alcohol intake are needed. Our aims were to investigate the performance of an epigenomic biomarker of alcohol consumption in a Mediterranean population using self-reported data and the biomarker gamma-glutamyl transferase (GGT); to examine the effects of alcohol (self-reported and biomarker-assessed) on epigenome-wide methylation; to analyze the association between alcohol (self-reported and biomarker-assessed) and telomere length and other aging biomarkers; and to explore the modulating effect of the Mediterranean diet (MedDiet). We performed blood epigenome-wide methylation studies (EWAS) in a Mediterranean cohort (aged 55–75 years). Self-reported alcohol consumption and MedDiet were assessed by questionnaires. A replication cohort (cohort 2) from the same area was also analyzed. For both cohorts, the DNA methylation-based biomarker (450-CpGs) was computed alongside epigenetic clocks for the following biological age acceleration metrics: DNAm telomere length, GrimAgeAcceleration, PhenoAgeAcceleration, and CausalityAgeYing (cohort 1). The association between the epigenomic biomarker and self-reported alcohol consumption was significant (p < 0.001) in both cohorts, but modest. However, the association was stronger when predicting high alcohol intake (AUC: 0.76; 95%CI: 0.65–0.86; p < 0.0001). In the EWAS, the hit (cg06690548-SLC7A11, in a cystine transporter that enhances glutathione production for antioxidant defense) was shared among the self-reported alcohol consumption, GGT, and the epigenomic biomarker, with alcohol linked to hypomethylation. We detected differential methylation in pre-selected oxidative stress-related genes. Enrichment analysis revealed “Rap1 signaling pathway” as the hit (p < 0.00001). High self-reported alcohol consumption and the epigenomic biomarker were associated with shorter telomere length (p < 0.05) in cohort 1. Additionally, a modulation by Mediterranean diet adherence was hypothesized. No significant associations were found between self-reported alcohol intake and the other aging biomarkers; however, the epigenomic score was directly associated with GrimAge, PhenoAge and CausAgeYing biomarkers in cohort 1 (p < 0.001), and two were replicated in cohort 2. In conclusion, alcohol intake has an impact on DNA methylation at the epigenome-wide level in this Mediterranean population, replicating the main hits from other populations and validating the epigenomic biomarker for intake, although improvement is needed. Moreover, several associations with aging biomarkers were observed.

## Linked entities

- **Genes:** SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657]

## Full-text entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, XRCC1 (X-ray repair cross complementing 1) [NCBI Gene 7515] {aka RCC, SCAR26}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, ARHGAP22 (Rho GTPase activating protein 22) [NCBI Gene 58504] {aka RhoGAP2, RhoGap22}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, NR5A2 (nuclear receptor subfamily 5 group A member 2) [NCBI Gene 2494] {aka B1F, B1F2, CPF, FTF, FTZ-F1, FTZ-F1beta}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, ADH1C (alcohol dehydrogenase 1C (class I), gamma polypeptide) [NCBI Gene 126] {aka ADH3}, ACSS2 (acyl-CoA synthetase short chain family member 2) [NCBI Gene 55902] {aka ACAS2, ACECS, ACS, ACSA, AceCS1, dJ1161H23.1}, CAT (catalase) [NCBI Gene 847], CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571] {aka CPE1, CYP2E, P450-J, P450C2E}, ADH1B (alcohol dehydrogenase 1B (class I), beta polypeptide) [NCBI Gene 125] {aka ADH2, HEL-S-117}, KIRREL3 (kirre like nephrin family adhesion molecule 3) [NCBI Gene 84623] {aka KIRRE, MRD4, NEPH2, PRO4502}, ALDH2 (aldehyde dehydrogenase 2 family member) [NCBI Gene 217] {aka ALDH-E2, ALDHI, ALDM}, SRXN1 (sulfiredoxin 1) [NCBI Gene 140809] {aka C20orf139, Npn3, SRX, SRX1}, GSS (glutathione synthetase) [NCBI Gene 2937] {aka CNSHA6, GSHS, HEL-S-64p, HEL-S-88n}, GPX2 (glutathione peroxidase 2) [NCBI Gene 2877] {aka GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI}, XDH (xanthine dehydrogenase) [NCBI Gene 7498] {aka XAN1, XDH/XO, XO, XOR}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, GSTM5 (glutathione S-transferase mu 5) [NCBI Gene 2949] {aka GSTM5-5, GTM5}, ADH7 (alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide) [NCBI Gene 131], CYBA (cytochrome b-245 alpha chain) [NCBI Gene 1535] {aka CGD4, p22-PHOX}, GLUL (glutamate-ammonia ligase) [NCBI Gene 2752] {aka DEE116, GLNS, GS, PIG43, PIG59}, GSTM1 (glutathione S-transferase mu 1) [NCBI Gene 2944] {aka GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, PCARE (photoreceptor cilium actin regulator) [NCBI Gene 388939] {aka C2orf71, RP54}, PHGDH (phosphoglycerate dehydrogenase) [NCBI Gene 26227] {aka 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG}, ADH6 (alcohol dehydrogenase 6 (class V)) [NCBI Gene 130] {aka ADH-5}, TRA2B (transformer 2 beta homolog) [NCBI Gene 6434] {aka Htra2-beta, PPP1R156, RAMELN, SFRS10, SRFS10, TRA2-BETA}, CYBB (cytochrome b-245 beta chain) [NCBI Gene 1536] {aka AMCBX2, CGD, CGDX, GP91-1, GP91-PHOX, GP91PHOX}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, ADH1A (alcohol dehydrogenase 1A (class I), alpha polypeptide) [NCBI Gene 124] {aka ADH1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, SCPEP1 (serine carboxypeptidase 1) [NCBI Gene 59342] {aka HSCP1, RISC}, ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide) [NCBI Gene 128] {aka ADH-3, ADHX, AMEDS, BMFS7, FALDH, FDH}, GCLM (glutamate-cysteine ligase modifier subunit) [NCBI Gene 2730] {aka GLCLR}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, TERF2IP (TERF2 interacting protein) [NCBI Gene 54386] {aka DRIP5, RAP1}, RNLS (renalase, FAD dependent amine oxidase) [NCBI Gene 55328] {aka C10orf59, RENALASE}, CACNG6 (calcium voltage-gated channel auxiliary subunit gamma 6) [NCBI Gene 59285], GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, ADH4 (alcohol dehydrogenase 4 (class II), pi polypeptide) [NCBI Gene 127] {aka ADH-2, HEL-S-4}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, RAP1A (RAP1A, member of RAS oncogene family) [NCBI Gene 5906] {aka C21KG, G-22K, KREV-1, KREV1, RAP1, SMGP21}, ALDH1B1 (aldehyde dehydrogenase 1 family member B1) [NCBI Gene 219] {aka ALDH5, ALDHX}, MAOA (monoamine oxidase A) [NCBI Gene 4128] {aka BRNRS, MAO-A}
- **Diseases:** cardiovascular disease (MESH:D002318), type 2 diabetes (MESH:D003924), chronic (MESH:D002908), mitochondrial dysfunction (MESH:D028361), alcohol use disorder (MESH:D000437), inflammation (MESH:D007249), injury to (MESH:D014947), neurodegeneration (MESH:D019636), metabolic syndrome (MESH:D024821), cancer (MESH:D009369), diabetes (MESH:D003920)
- **Chemicals:** cystine (MESH:D003553), 5-mC (-), phosphatidylethanol (MESH:C051521), Ethyl glucuronide (MESH:C093924), RNS (MESH:D026361), cysteine (MESH:D003545), lipid (MESH:D008055), GSH (MESH:D005978), glucose (MESH:D005947), folate (MESH:D005492), ROS (MESH:D017382), Alcohol (MESH:D000438), triglyceride (MESH:D014280), S-adenosyl methionine (MESH:D012436), 5-methylcytosine (MESH:D044503), cholesterol (MESH:D002784), Ethanol (MESH:D000431)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]
- **Mutations:** cysteine/glutamate, Rs895819

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938750/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938750/full.md

## References

154 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938750/full.md

---
Source: https://tomesphere.com/paper/PMC12938750